What You Should Know:
– Cority, a provider of environmental, health, and safety (EHS) and sustainability software solutions acquires Meddbase, a pioneer in cloud-native occupational medicine and enterprise medical practice management software. Financial details of…
Continue Reading
In this interview, Dr. Samir Shah, Chief Medical Officer at Qure.ai, shares why achieving FDA approval is crucial for their AI solutions and for fostering trust in the technology. Dr. Shah discusses how their…
Continue Reading
Barking, Havering and Redbridge University Hospitals NHS Trust will trial a whole-brain computer interface that uses ultrasound to measure and modulate brain-wide activity.
The ultrasonic neural interface, developed by US-based non-profit Forest Neurotech, could be…
The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued fresh guidance to help medical device manufacturers prepare for upcoming regulatory changes.
The post-market surveillance (PMS) regulation for medical devices comes into force across England,…
On his first day in office of his second term, President Donald Trump revoked Joe Biden’s 2023 executive order, which aimed to establish standards for the safe, secure and trustworthy development of AI across…
Continue Reading
What You Should Know:
– Denver Health, an integrated health system and Colorado’s primary safety-net provider has partnered with Nabla, an ambient AI technology for healthcare, to deploy its AI-powered assistant across its network of…
Continue Reading
Dr. Heather Bassett, Chief Medical Officer with Xsolis
As healthcare organizations explore the potential of AI, they face a complex challenge: balancing innovation with caution. While some embrace AI as a solution to numerous problems, others remain concerned about its risks,…
Continue Reading
Simon Johns, Director, Medical Information and Marketed Product Safety at IQVIA
The demand for accurate and timely medical information has never been greater. As healthcare providers and patients navigate an increasingly complex landscape of therapies…
Continue Reading
Revolutionary Phase III Trial Results
Bayer has announced groundbreaking topline results from their Phase III QUANTI studies evaluating gadoquatrane, an innovative gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI). The revolutionary aspect of this…
Clinical safety officers (CSOs) have warned that patient safety could be put at risk by healthcare organisations’ historical failure to comply with digital clinical safety standards.
The Digital Health Networks CSO Council has issued an…
